Clinical Trial Update – Blood Glucose Levels in Pre-Diabetic participants – 2017

February 9, 2017

As you may be aware, we engaged Medlab Clinical Limited in December 2014 to conduct a Phase IIA Double Blind Placebo Controlled Clinical Trial investigating the Efficacy and Safety of Arborvitae’s Health and Wellbeing Supplement in Improving Blood Glucose Levels in Pre-Diabetic participants.

The Clinical Trial is progressing well (albeit slowly). We now only need 6 more participants to complete the total of 120 participants required. The Clinical Trial is being conducted in Sydney and Brisbane by Medlab.

We are keen to hear from people that may fall within the Pre-diabetics category (with a fasting blood glucose reading in the range of 6.1 to 6.9mmol/L). Certain travel expenses will be paid and all participants will receive two bottles of Arborvitae Health and Wellbeing Supplement upon completion.

Please contact Serena Dalforno at Medlab on (02) 8188 0311 for further information on the clinical trial if interested.

The clinical trial is now closed and waiting for the final participants to conclude their trial testing period.

News & Insights

How long should someone be drinking Arborvitae before they see a difference?Read More
Chronic illnesses diagram
Inflammation & the Immune SystemRead More
Molecule chain
Clinical Trial Update - Blood Glucose Levels in Pre-Diabetic participants - 2017Read More
2GB Radio Interview Discusses Arborvitae & Diabetic RetinopathyRead More